Dubai, UAE – Valeo Health ME, a UAE-based healthtech startup specializing in AI-driven personalized care, has secured $12 million in a Series B funding round led by Flintera, with participation from Nuwa Capital, FJ Labs, Oryx Fund, Mindshift Capital, Oraseya Capital, and Eirad.
This brings Valeo’s total funding to $20 million since its 2021 founding by Sundeep S., Nadin Karadag, and Ankur Majumder.
The investment will accelerate the development of Valeo’s AI-powered platform, which delivers customized treatment plans and home healthcare services.
The company plans to expand its footprint across Saudi Arabia, the UAE, and other GCC markets, enhancing accessibility to personalized healthcare solutions.
“With this funding, we’re poised to redefine healthcare delivery in the region through scalable AI innovations,” said a Valeo Health spokesperson. The startup combines AI analytics with clinical expertise to address gaps in preventive and therapeutic care.